Expression of mRNAs for telomeric repeat binding factor (TRF)-1 and TRF2 in atypical adenomatous hyperplasia and adenocarcinoma of the lung

Clinical Cancer Research

Volumn 9, Issue 3, 2003, Pages 1105-1111

  Nakanishi, Kuniaki ^a   Kawai, Toshiaki ^a   Kumaki, Fumiyuki ^a   Hiroi, Sadayuki ^a   Mukai, Makio ^b   Ikeda, Eiji ^b   Koering, Catherine Elaine ^c   Gilson, Eric ^c  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITÉ DE LYON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; TELOMERIC REPEAT BINDING FACTOR 1; TELOMERIC REPEAT BINDING FACTOR 2; UNCLASSIFIED DRUG;

ARTICLE; CANCER GRADING; CANCER SURGERY; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; LUNG ADENOMA; LUNG ALVEOLUS CELL CARCINOMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE;

ADENOCARCINOMA; HUMANS; HYPERPLASIA; IN SITU HYBRIDIZATION; LUNG NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TELOMERIC REPEAT BINDING PROTEIN 1; TELOMERIC REPEAT BINDING PROTEIN 2; TEMPERATURE;

EID: 0037341373     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Shimosato, Y., Kodama, T., and Kameya, T. Morphogenesis of peripheral type adenocarcinoma of the lungs. In: Y. Shimosato, M. R. Melamed, and P. Nettesheim (eds.), Morphogenesis of Lung Cancer, Vol. 1, pp. 65-89. Boca Raton, FL: CRC Press, 1982.
2. Travis, W. D., Colby, T. V., Corrin, B., Shimosato, T., and Brambilla, E. Histological Typing of Lung and Pleural Tumours, 3rd ed., p. 36. WHO, Springer-Verlag, 1999.
3. Kitamura, H., Kameda, Y., Ito, T., and Hayashi, H. Atypical adenomatous hyperplasia of the lung. Am. J. Clin. Pathol., 111: 610-622, 1999.
4. Mori, M., Rao, S. K., Popper, H. H., Cagle, P. T., and Fraire, A. E. Atypical adenomatous hyperplasia of the lung: a possible forerunner in the development of adenocarcinoma of the lung. Mod. Pathol., 14: 72-84, 2001.
5. Blackburn, E. H. Structure and function of telomeres. Nature (Lond.), 350: 569-573, 1991.
6. Counter, C. M., Avilion, A. A., LeFeuvre, C. E., Stewart, N. G., Greider, C. W., Harley, C. B., and Bacchetti, S. Telomerase shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J., 11: 1921-1929, 1992.
7. Blasco, M. A., Funk, W., Villeponteau, B., and Greider, C. W. Functional characterization and developmental regulation of mouse telomerase RNA. Science (Wash. DC), 269: 1267-1272, 1995.
8. Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., and Shay, J. W. Specific association of human telomerase activity with immortal cells and cancer. Science (Wash. DC), 266: 2011-2015, 1994.
9. Blasco, M. A., Rizen, M., Greider, C. W., and Hanahan, D. Differential regulation of telomerase activity and telomerase RNA during multi-stage tumorigenesis. Nat. Genet., 12: 200-204, 1996.
10. Avilion, A. A., Piatyszek, M. A., Gupta, J., Shay, J. W., Bacchetti, S., and Greider, C. W. Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues. Cancer Res., 56: 645-650, 1996.
11. Yashima, K., Litzky, L. A., Kaiser, L., Rogers, T., Lam, S., Wistsuba, I. I., Milchgrub, S., Srivastava, S., Piatyszek, M. A., Shay, J. W., and Gazdar, A. F. Telomerase expression in respiratory epithelium during the multistage pathogenesis of lung carcinomas. Cancer Res., 57: 2373-2377, 1997.
12. Meyerson, M., Counter, C. M., Eaton, E. N., Ellisen, L. W., Steiner, P., Caddle, S. D., Ziaugra, L., Beijersbergen, R. L., Davidoff, M. J., Liu, Q., Bacchetti, S., Haber, D. A., and Weinberg, R. A. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell, 90: 785-795, 1997.
13. Weinrich, S. L., Pruzan, R., Ma, L., Ouellette, M., Tesmer, V. M., Holt, S. E., Bodnar, A. G., Lichtsteiner, S., Kim, N. W., Trager, L. B., Taylor, R. D., Carlos, R., Andrews, W. H., Wright, W. E., Shay, J. W., Harley, C. B., and Morin, G. B. Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT. Nat. Genet., 17: 498-502, 1997.
14. Nakayama, J., Tahara, H., Tahara, E., Saito, M., Ito, K., Nakamura, H., Nakanishi, T., Tahara, E., Ide, T., and Ishikawa, F. Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas. Nat. Genet., 18: 65-68, 1998.
15. van Steensel, B., and de Lange, T. Control of telomere length by the human telomeric protein TRF1. Nature (Lond.), 385: 740-743, 1997.
16. van Steensel, B., Smogorzewska, A., and de Lange, T. TRF2 protects human telomeres from end-to-end fusions. Cell, 92: 401-413, 1998.
17. Smogorzewska, A., van Steensel, B., Bianchi, A., Oelmann, S., Schaefer, M. R., Schnapp, G., and de Lange, T. Control of human telomere length by TRF1 and TRF2. Mol. Cell. Biol., 20: 1659-1668, 2000.
18. Ancelin, K., Brunori, M., Bauwens, S., Koering, C. E., Brun, C., Ricoul, M., Pommier, J. P., Sabatier, L., and Gilson, E. A. Targeting assay to study the cis functions of human telomeric proteins: evidence for an inhibition of telomerase by TRF1 and for activation of telomere degradation by TRF2. Mol. Cell. Biol., 22: 3474-3487, 2002.
19. Kumaki, F., Kawai, T., Hiroi, S., Shinomiya, N., Ozeki, Y., Ferrans, V. J., and Torikata, C. Telomerase activity and expression of human telomerase RNA component and human telomerase reverse transcriptase in lung carcinomas. Hum. Pathol., 32: 188-195, 2001.
20. Fujiwara, M., Okayasu, I., Takemura, T., Tanaka, I., Masuda, R., Furuhata, Y., Noji, M., Oritsu, M., Kato, M., and Oshimura, M. Telomerase activity significantly correlates with chromosome alterations, cell differentiation, and proliferation in lung adenocarcinomas. Mod. Pathol., 13: 723-729, 2000.
21. Marchetti, A., Bertacca, G., Buttitta, F., Chella, A., Quattrocolo, G., Angeletti, C. A., and Bevilacqua, G. Telomerase activity as a prognostic indicator in stage I non-small cell lung cancer. Clin. Cancer Res., 5: 2077-2081, 1999.
22. Hiyama, K., Hiyama, E., Ishioka, S., Yamakido, M., Inai, K., Gazdar, A. F., Piatyszek, M. A., and Shay, J. W. Telomerase activity in small-cell and non-small cell lung cancers. J. Natl. Cancer Inst. (Bethesda), 87: 895-902, 1995.
23. Albanell, J., Lonardo, F., Rusch, V., Engelhardt, M., Langenfeld, J., Han, W., Klimstra, D., Venkatraman, E., Moore, M. A. S., and Dmitrovsky, E. High telomerase activity in primary lung cancers: association with increased cell proliferation rates and advanced pathologic stage. J. Natl. Cancer Inst. (Bethesda), 89: 1609-1615, 1997.
24. Taga, S., Osaki, T., Ohgami, A., Imoto, H., and Yasumoto, K. Prognostic impact of telomerase activity in non-small cell lung cancers. Ann. Surg., 230: 715-720, 1999.
25. Kawai, T., Hiroi, S., and Torikata, C. Expression in lung carcinomas of platelet-derived growth factor and its receptors. Lab. Investig., 77: 431-436, 1997.
26. Vassetzky, N., Gaden, F., Brun, C., Gasser, S. M., and Gilson, E. Taz1P and Teb1p, two telobox proteins in Schizosaccharomyces pombe recognize different telomere-related DNA sequences. Nucleic Acids Res., 27: 4687-4694, 1999.
27. Bilaud, T., Brun, C., Ancelin, K., Koering, C. E., Laroche, T., and Gilson, E. Telomeric localization of TRF2, a novel human telobox protein. Nat. Genet., 17: 236-239, 1997.
28. Nakanishi, K., Kawai, T., Kumaki, F., Hiroi, S., Mukai, M., and Ikeda, E. Expression of human telomerase mRNA component (hTERC) and telomerase reverse transcriptase (hTERT) mRNA in atypical adenomatous hyperplasia of the lung. Hum. Pathol., 33: 697-702, 2002.
29. Chomczyski, P., and Sacchi, N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162: 156-159, 1987.
30. Bodmar, A. G., Kim, N. W., Effros, R. B., and Chiu, C. P. Mechanism of telomerase induction during T-cell activation. Exp. Cell Res., 228: 58-64, 1996.
31. Weng, N. P., Palmer, L. D., Levine, B. L., Lane, H. C., June, C. H., and Hodes, R. J. Tales of tails: regulation of telomere length and telomerase activity during lymphocyte development, differentiation, activation and aging. Immunol. Rev., 160: 43-54, 1997.
32. Tahara, H., Kuniyasu, H., Yokozaki, H., Yasui, W., Shay, J. W., Ide, T., and Tahara, E. Telomerase activity in preneoplastic and neoplastic gastric and colorectal lesions. Clin. Cancer Res., 1: 1245-1251, 1995.
33. Maruyama, Y., Hanai, H., Fujita, M., and Kaneko, E. Telomerase length and telomerase activity in carcinogenesis of the stomach. Jpn. J. Clin. Oncol., 27: 216-220, 1997.
34. Yashima, K., Ashfag, R., Nowak, J., von Gruenigen, V., Michgrub, S., Rathi, A., Albores-Saavedra, J., Shay, J. W., and Gazder, A. F. Telomerase activity and expression of its RNA component in cervical lesions. Cancer (Phila.), 82: 1319-1327, 1998.
35. Matsutani, N., Yokozaki, H., Tahara, E., Tahara, H., Kuniyasu, H., Haruma, K., Chayama, K., Yasui, W., and Tahara, E. Expression of telomeric repeat binding factor 1 and 2 and TRF1-interacting nuclear protein 2 in human gastric carcinomas. Int. J. Oncol., 19: 507-512, 2000.
36. Mergny, J. L., Riou, J. F., Mailliet, P., Teulade-Fichou, M. P., and Gilson, E. Natural and pharmacological regulation of telomerase. Nucleic Acids Res., 30: 839-865, 2002.